For decades we have been told that diabetes is progressive, and it can be prevented by simply taking more medications, diet and exercise. However, something is absolutely wrong with this conventional wisdom.
Over 400 million people live with either prediabetes or type 2 diabetes in the world today, and this number is growing. It is high time to reverse this trend.
GlucoSpace.com was founded in 2019 with the goal of reversing type 2 diabetes in 200 million people by 2035. Our mission is inspired by our founding story, and continues to guide us today.
A Personal Experience
GlucoSpace founder suddenly collapsed and was rushed to the Accident & Emergency diagnosed with Diabetic Ketoacidosis (DKA) including diabetic retinopathy, hyperglycaemia, high blood pressure, chronic kidney disease and nearly died at the hospital with type 2 diabetes and its complications.
GlucoSpace.com Is Born
Our founder, with colleagues carried out extensive research in England establishing the scientific foundation for prediabetes and type 2 diabetes reversal and unwavering commitment to being evidence-based. In as little as 12 weeks. blood glucose levels normalised, weaned off insulin and reversed type 2 diabetes.
Millions signed up with GlucoSpace.com. Our simple educational program normalizes blood glucose levels, which reduces the need for diabetes medication - saving money and eliminating side effects.
Sustainable Prediabetes and Type 2 Diabetes Reversal
1.5% average A1c reduction after 6 months and improved blood glucose control. One of the key benefits of the GlucoSpace.com program. Many of our members achieved reduction or eliminated other metabolic disorders but they lose weight too on average a weight loss of 7.5 kg between 6-12 months as well as reducing or eliminating the need for prescription medications.
GlucoSpace.com aims to reverse prediabetes and type 2 diabetes in hundreds of millions of people worldwide
So much of our story is still untold, and we’re looking forward to the journey on our way to reversing prediabetes and type 2 diabetes in 200 million people by 2035.